Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NINTEDANIB ESYLATE for Interstitial lung disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 21 adverse event reports in the FDA FAERS database where NINTEDANIB ESYLATE was used for Interstitial lung disease.

Most Reported Side Effects for NINTEDANIB ESYLATE

Side Effect Reports % Deaths Hosp.
Diarrhoea 54 46.2% 14 16
Nausea 24 20.5% 6 6
Decreased appetite 20 17.1% 1 9
Fatigue 20 17.1% 5 3
Vomiting 20 17.1% 10 2
Dyspnoea 18 15.4% 5 5
Weight decreased 17 14.5% 6 5
Off label use 16 13.7% 2 10
Constipation 13 11.1% 5 2
Dizziness 13 11.1% 5 2
Headache 13 11.1% 0 2
Cough 12 10.3% 0 3
Cerebrovascular accident 11 9.4% 1 9
Chest pain 11 9.4% 5 0
Death 11 9.4% 11 3

Other Indications for NINTEDANIB ESYLATE

Idiopathic pulmonary fibrosis (48) Pulmonary fibrosis (22) Product used for unknown indication (15) Lung adenocarcinoma (5)

Other Drugs Used for Interstitial lung disease

NINTEDANIB (2,999) PIRFENIDONE (1,657) RITUXIMAB (1,074) PREDNISOLONE (879) MYCOPHENOLATE MOFETIL (822) METHYLPREDNISOLONE (744) CYCLOPHOSPHAMIDE (623) TACROLIMUS (565) PREDNISONE (453) CYCLOSPORINE (385)

Related Pages

NINTEDANIB ESYLATE Full Profile All Interstitial lung disease Drugs NINTEDANIB ESYLATE Demographics NINTEDANIB ESYLATE Timeline